Noonan to Head Global Regulatory PolicyMarch 18, 2014 2:50 pm
Contact: John Lewis
Karen Noonan to Head Global Regulatory Policy for ACRO
Decade of health policy, alliance development and legislative experience
March 18, 2014 – WASHINGTON, DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that Karen A. Noonan has joined the association in the newly created position of Vice President, Global Regulatory Policy. Noonan most recently served as Senior Advisor for Health Policy at Onyx Pharmaceuticals and was previously Director of State Government Affairs and Grassroots Advocacy at the American Society of Health System Pharmacists (ASHP).
“We welcome Karen to the ACRO team and are confident she will continue to build our relationships with regulators and alliance partners in the United States, Europe and around the globe,” said ACRO Executive Director Doug Peddicord, Ph.D. “We see a tremendous opportunity for CROs to take a more pro-active position in regulatory policy as our members play an increasingly important role in medical product development.”
ACRO also announced that John Lewis will serve as Senior Vice President, Policy and Public Affairs. For the past five years, Mr. Lewis has held the position of Vice President of Public Affairs with the association.
The Association of Clinical Research Organizations (ACRO) represents companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics and medical devices. The association provides an active voice for the CRO industry globally. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 100,000 professionals worldwide and annually conduct more than 11,000 clinical trials involving nearly two million participants in 115 countries. For more information, please visit www.www.acrohealth.org. Twitter @acrohealth. YouTube @ACROHealthChannel. Facebook.